Analyst Recommendations
Barclays analyst issues EQUAL-WEIGHT recommendation for ADI on May 20, 2024 05:40AM ET. The previous analyst recommendation was Equal-Weight.ADI was trading at $214.08 at issue of the analyst...May 20, 2024 ADI -0.11%
Barclays analyst issues OVERWEIGHT recommendation for EXR on May 20, 2024 05:49AM ET. The previous analyst recommendation was Overweight.EXR was trading at $151.89 at issue of the analyst...May 20, 2024 EXR 1.82%
Barclays analyst issues EQUAL-WEIGHT recommendation for RSKD on May 20, 2024 05:49AM ET. The previous analyst recommendation was Equal-Weight.RSKD was trading at $5.97 at issue of the analyst...May 20, 2024 RSKD 0.64%
Barclays analyst issues OVERWEIGHT recommendation for PSA on May 20, 2024 05:50AM ET. The previous analyst recommendation was Overweight.PSA was trading at $288.67 at issue of the analyst...May 20, 2024 PSA 2.27%
Barclays analyst issues EQUAL-WEIGHT recommendation for PRVA on May 20, 2024 05:47AM ET. The previous analyst recommendation was Equal-Weight.PRVA was trading at $16.9 at issue of the analyst...May 20, 2024 PRVA 2.44%
Barclays analyst issues OVERWEIGHT recommendation for NVDA on May 20, 2024 05:44AM ET. The previous analyst recommendation was Overweight.NVDA was trading at $924.79 at issue of the analyst...May 20, 2024 NVDA 0.24%
Barclays analyst issues OVERWEIGHT recommendation for ZS on May 20, 2024 05:42AM ET. The previous analyst recommendation was Overweight.ZS was trading at $178.86 at issue of the analyst...May 20, 2024 ZS 3.01%
Barclays analyst issues OVERWEIGHT recommendation for WMT on May 20, 2024 05:51AM ET. The previous analyst recommendation was Overweight.WMT was trading at $64.65 at issue of the analyst...May 20, 2024 WMT 0.08%
H.C. Wainwright analyst issues BUY recommendation for PRME on May 20, 2024 06:05AM ET. PRME was trading at $7.08 at issue of the analyst recommendation.The overall analyst consensus...May 20, 2024 PRME -2.20%
H.C. Wainwright analyst issues BUY recommendation for ERAS on May 20, 2024 06:11AM ET. The previous analyst recommendation was Buy.ERAS was trading at $1.97 at issue of the...May 20, 2024 ERAS 14.09%